OPTISCAN IMAGING LIMITED — Investor Relations & Filings

Optiscan Imaging Limited specializes in the development and commercialization of endomicroscopic imaging technologies. The company’s core expertise lies in confocal laser endomicroscopy, which enables real-time, high-resolution digital pathology at the cellular level. Its proprietary technology allows clinicians and researchers to perform virtual biopsies, visualizing tissue architecture in vivo without the need for physical tissue removal. Key products include the ViewnVivo system for preclinical research and the Five2 platform designed for clinical applications, particularly in the early detection and management of cancer. These systems are utilized across various medical fields, including oncology, gastroenterology, and oral health, to improve diagnostic accuracy and surgical precision. By integrating advanced optics and software, the company provides tools for immediate intraoperative decision-making and longitudinal biological studies.